On December 30, 2016, Guangzhou Rhfay Biotechnology Co., Ltd. was successfully listed in Guangzhou equity trading center. There are four enterprises listed in Guangzhou stock exchange this time. Rhfay biotechnology is the first enterprise to make a speech and ring the bell.
Liu Xudong, deputy general manager of the company, attended the listing ceremony on behalf of Li Yousheng, chairman of Rhfay biology, and delivered a speech. He said that as a high-tech enterprise with rapid development, Rhfay biology has achieved rapid development under the leadership of the chairman of the board. At present, its products have been distributed in more than 30 provinces, municipalities and autonomous regions across the country. At present, the company has nearly 30 products, which are sold in the market. By 2018, the company's products will reach more than 100.
At present, Rhfay biology has signed strategic cooperation agreements with internationally renowned universities and scientific research institutions such as Cambridge University and Lancaster University. In 2017, the company will launch the international development strategy to lay a solid foundation for the company to explore overseas markets.
As a practitioner of the human health industry, Rhfay biology takes "committed to the most valuable IVD products and services" as the enterprise development concept. Under the care of the party, the government and leaders from all walks of life, the company is developing at a high speed, always adhering to the core values of "people-oriented, practical, innovative and efficient", and adhering to the people-oriented talent strategy, Pay attention to the internal talent training of the company. The development of Rhfay is inseparable from the efforts of all Rhfay people. Thank all those who silently support the development of Rhfay.
